Patheon Completes Intermediate Scale Processing Facility at its Cincinnati Plant. TORONTO, Oct. 9 /CNW/ - Patheon, a global provider of drug development and manufacturing services to the international pharmaceutical industry is pleased to announce the expansion of services utilizing a new..

Cardinal pays up for drug slip-ups. Cardinal Health, Ohio's largest public company, lost up to $1 billion in sales while three of its warehouses were restricted in their drug shipments.

Cardinal Health pays $105,000 fine. Cardinal Health has paid $105,000 to settle the state Board of Pharmacy's charge that the drug wholesaler failed to report suspicious drug orders at its Findlay warehouse.

Par Pharmaceutical Announces Resizing of Generic Unit to Optimize Strong First-to-File Pipeline. Par Pharmaceutical Companies, Inc. today announced a resizing of its generic unit as part of an ongoing strategic assessment of its businesses.

Synta Pharmaceuticals Earns $25 Million from GlaxoSmithKline for Achieving Elesclomol Milestones. Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it has achieved..

Zacks Analyst Blog Highlights: Actions Semiconductor Corp., Barr.. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.

FDA Approves AstraZeneca's Seroquel XR for the Treatment of.. AstraZeneca today announced that the US Food and Drug Administration has approved once-daily SEROQUEL XR Extended-Release Tablets for the acute treatment of the depressive episodes associated with bipolar..

Izard Nobel LLP Announces Class Action Lawsuit against Biovail Corporation. HARTFORD, Conn. The law firm of Izard Nobel LLP, which has significant experience representing investors in prosecuting claims of securities fraud, announces that a lawsuit seeking class action status has..

Flour recalled over excessive nutrient levels. The Canadian Food Inspection Agency has issued a warning for No Name brand of all-purpose flour because it may contain excessively high levels of folic acid, iron, niacin, riboflavin and thiamine.

A Forecast Insight Report into the Antidiabetics Market - Switching.. A Forecast Insight Report into the Antidiabetics Market - Switching to New Molecule Antidiabetics Drives Market Growth 2008-10-10 11:44:02 - - Research and Markets has announced the..

SCOLR Pharma Announces Completion Of Patient Enrollment And Dosing For Pivotal Clinical Trial Evaluating Extended Release Ibuprofen. SCOLR Pharma, Inc. announced the completion of patient enrollment and dosing for the third of its three pivotal trials to evaluate the safety and efficacy of its formulation of 12-hour extended-release ibuprofen for the over-the-counter market. The Company expects to report top-line results from this pivotal trial in November 2008.

Evotec Announces Phase I Initiation With P2X7 Antagonist. Evotec AG announced today that Phase I clinical studies for its proprietary, small molecule P2X7 receptor antagonist have been initiated. The P2X7 receptor is an ATP-gated ion channel primarily expressed on cells of the immune system and is thought to play an important role in inflammatory processes through the regulation of a number of proinflammatory cytokines.

Is Couple Therapy Better Than Individual Psychotherapy In Alcoholism? Alcohol abuse serves as a chronic stressor between partners and has a deleterious effect on relationship functioning.

Ranolazine Safe And Effective For Angina. Researchers from Syracuse Preventive Medicine, NY, USA discuss a new drug called ranolazine that has been deemed a safe and effective treatment for chronic stable angina. Drs Stephen Nash and David Nash discuss this new treatment option in a New Drug Class paper published in The Lancet. Angina is characterized by severe chest pain caused by a lack of blood and oxygen supply to the heart muscle, often due to ischemic heart disease.

Inspire Initiates Phase 1 Trial Of INS117548 For Glaucoma. Inspire Pharmaceuticals, Inc. announced that it has initiated a Phase 1 clinical trial with INS117548 Ophthalmic Solution for the treatment of glaucoma. The placebo-controlled, dose-escalating trial is designed to evaluate the safety, tolerability and intraocular pressure -lowering effects of INS117548 in approximately 60 subjects with early stage glaucoma or ocular hypertension.

5.8m Grant Received By Boston Medical Center To Improve Quality Of Life Of Older Americans. Boston Medical Center has received a $5,807,469 grant over five years from the National Institute on Aging to fund the Boston Claude D. Pepper Older Americans Independence Center. BMC's Pepper Center is one of only 11 Pepper Centers in the country. The Claude D. Pepper Older Americans Independence Center Program was established in honor of Claude D. Pepper, the late U.S. senator from Florida.

In Growing 80-Plus Population Study Finds Stroke-Prevention Surgery To Be Safe. New research published in the October issue of Journal of the American College of Surgeons challenges the current opinion that patients in their eighties, who are often deemed "high-risk" due to their advanced age, should not undergo carotid endarterectomy - a stroke-preventing surgical procedure that clears blockages from the neck's carotid arteries.

Medtronic's Third-Generation Endeavor� Resolute Drug-Eluting Stent Maintains Strong Efficacy And Safety Profile At Two Years. Of those treated with the Endeavor� Resolute drug-eluting stent from Medtronic, Inc., in the RESOLUTE IDE trial only two patients required repeat procedures - a remarkably low 1.5 percent rate of target lesion revascularization - at two years following implant, according to data released today at the Transcatheter Cardiovascular Therapeutics meeting.

Boston Residents Debate On Pros, Cons Of Lifting Exemption Of Bars From Smoking Ban Law. A rigid smoking ban proposed by Boston city officials has sparked public debates. The Boston Public Health Commission is set to implement soon a sweeping tobacco prohibition to cover bars, which were exempt from the 2004 smoking ban. Thu, 9 Oct 2008 10:09:06 GMT.

Canada Continues To Wage Battle Against Listeria. While China and the rest of the world are grappling with the melamine scare found in milk and dairy products, Canada's health battle is still against the deadly listeria. Thu, 9 Oct 2008 13:54:58 GMT.